Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-09

Clinical Trial Update: Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars [NA]

View source ↗

Summary

A completed clinical trial evaluating the safety and performance of Princess FILLER for treating facial lipoatrophy, facial asymmetry, and debilitating scars.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Princess FILLER (Cross-linked hyaluronic acid dermal filler)

Snippet

Sponsor: Croma-Pharma GmbH | Conditions: Facial Lipoatrophy, Morphological Asymmetry of the Face | NA | Status: COMPLETED